Search for: "Boehringer-Ingelheim"
Results 121 - 140
of 443
Sorted by Relevance
|
Sort by Date
9 Jul 2018, 6:30 pm
Boehringer Ingelheim Pharmaceuticals, Inc., 2018 WL 3028972 (CADC June 19, 2018). [read post]
9 Jul 2018, 6:30 pm
Boehringer Ingelheim Pharmaceuticals, Inc., 2018 WL 3028972 (CADC June 19, 2018). [read post]
28 Nov 2017, 1:05 pm
Medical writing assistance, supported financially by Boehringer Ingelheim, was provided by Elizabeth Ng of FleishmanHillard Fishburn, London, U.K., during the preparation of this paper. [read post]
26 Jul 2023, 1:53 am
In an invalidity lawsuit filed by the Brazilian affiliate of Sun Pharma against Boehringer Ingelheim, Federal Judge Carvalho, sitting at the 9th Federal District Court in Rio de Janeiro, has granted a preliminary injunction ordering the Brazilian Patent and Trademark Office (BRPTO) to annotate that a second medical use patent (covering Ofev) doesn’t prevent the manufacturing and/or selling of generic or brand-generic nintedanib-based drugs for other uses. [read post]
15 Jan 2014, 5:43 am
Herndon of the Southern District of Illinois has ordered that Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
17 Jun 2013, 10:27 am
” Boehringer Ingelheim Vetmedica v. [read post]
19 Oct 2014, 10:27 pm
However, Pradaxa, manufactured by Boehringer Ingelheim, has been the subject of numerous dangerous drug lawsuits due to the fact that patients taking the drug may develop dangerous and irreversible internal bleeding disorders, including intracranial bleeding. [read post]
3 Mar 2015, 8:15 am
Pradaxa maker, Boehringer Ingelheim, has announced it will be reducing its workforce in New England as well as internationally as it faces defective products lawsuits and declining sales of its blood-thinning medication. [read post]
6 Feb 2013, 9:34 am
Boehringer Ingelheim reportedly spent $464 million on advertising to promote the drug. [read post]
17 Dec 2010, 11:05 am
Boehringer Ingelheim Pharmaceuticals, Inc., slip op. (8th Cir. [read post]
29 Nov 2012, 3:47 am
When reports began to surface of bleeding problems, Boehringer Ingelheim recommended dialysis to flush the drug out. [read post]
14 Nov 2007, 12:00 am
The June 2007 edition of LESI's les Nouvelles carried an interesting article by Dr Adrian Carter from Boehringer Ingelheim on co-promotion and co-marketing partnerships in the pharmaceutical industry. [read post]
19 Dec 2010, 9:44 am
--Naik v Boehringer Ingelheim Pharm, Inc., 7thCir, November 22, 2010, No. 09-2960: Summary judgment upheld for employer after 53-year-old former pharmaceutical sales rep failed to show that termination based on falsification of call records, was pretext for age and national origin (Indian) discrimination in violation of the Age Discrimination in Employment Act (ADEA) and Title VII.The employer's legitimate non-discriminatory reason (LNDR) was pretty damning against the… [read post]
30 Apr 2012, 9:36 pm
The estate of a woman who bled to death is suing pharmaceutical company Boehringer Ingelheim for her wrongful death. [read post]
21 Mar 2017, 12:23 pm
Boehringer Ingelheim Pharmaceuticals, Inc. markets this prescription anticoagulant drug. [read post]
17 Sep 2016, 7:08 am
Specifically, the decision is being lauded by Boehringer Ingelheim, the makers of Pradaxa, according to a recent news feature from FiercePharma. [read post]
17 Sep 2016, 7:08 am
Specifically, the decision is being lauded by Boehringer Ingelheim, the makers of Pradaxa, according to a recent news feature from FiercePharma. [read post]
26 Jan 2010, 9:59 pm
The Metes and Bounds of Obviousness-type Double Patenting By Kevin E. [read post]
18 Jul 2012, 3:58 pm
So even though Pradaxa has been associated with problems like pulmonary embolism and other heart issues, it remains a blockbuster product for Boehringer Ingelheim. [read post]
28 Jul 2011, 11:19 am
Boehringer Ingelheim Pharmaceuticals, No. 10-3129, slip op. (8th Cir. [read post]
